Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Santen pays $600mm for Asian and European rights to Merck's glaucoma products

Executive Summary

Santen Pharmaceutical Co. Ltd. (ophthalmic and musculoskeletal therapies) paid $600mm up front for exclusive rights in Japan and key markets in Europe and Asia Pacific to Merck & Co. Inc.’s marketed glaucoma products. Merck will also get sales milestones.
Deal Industry
  • Pharmaceuticals
Deal Status
  • Final
Deal Type
  • Alliance
    • Marketing-Licensing

Related Companies